High renal resistive index in hypertensive patients is also associated with serum homocysteine level

Şakir Özgür Keşkek1, Yavuz Çinar, Sinan Kirim

  • 1Department of Internal Medicine, Numune Training and Research Hospital, Yüreğir, Adana, 01240, Turkey, drkeskek@yahoo.com.

Insights

Newly diagnosed hypertension is linked to higher homocysteine levels and renal resistive index. Elevated homocysteine is associated with hypertension and correlates with renal resistive index, indicating a potential marker for cardiovascular risk.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Hypertension, elevated homocysteine, and increased renal resistive index are risk factors for atherosclerosis and cardiovascular diseases.
  • Understanding the interplay between these factors is crucial for managing hypertension-related complications.

Purpose of the Study:

  • To investigate the association between serum homocysteine levels and renal resistive index in patients newly diagnosed with hypertension.

Main Methods:

  • A case-control study included 221 subjects: 116 with newly diagnosed hypertension and 105 healthy controls.
  • Measurements included renal resistive index, serum homocysteine, insulin concentrations, and blood pressure.

Main Results:

  • Hypertensive patients exhibited higher renal resistive index, serum homocysteine, and insulin levels compared to controls (p=0.006, p<0.001, respectively).
  • Serum homocysteine levels were significantly associated with hypertension (OR 9.5, p<0.001).
  • Both homocysteine and insulin levels positively correlated with renal resistive index (r=0.372, p=0.001 and r=0.392, p<0.001, respectively).

Conclusions:

  • A high renal resistive index in hypertensive patients is associated with elevated homocysteine levels.
  • Homocysteine may serve as a biomarker for renal vascular changes in hypertension.
Abstract

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
664
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
748
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.7K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
747